Chinese Journal of Reparative and Reconstructive Surgery, 2022 · DOI: 10.7507/1002-1892.202204044 · Published: October 1, 2022
This study explores a new approach to cartilage repair by creating a scaffold that not only supports new cartilage growth but also fights inflammation. Inflammation often hinders the success of cartilage regeneration, so a scaffold with anti-inflammatory properties could significantly improve outcomes. The researchers used a substance called xanthohumol, extracted from hops, known for its anti-inflammatory effects. They loaded this substance into a poly(lactic-co-glycolic acid) (PLGA) scaffold, a material commonly used in tissue engineering, to create a drug-eluting scaffold. The study involved both in vitro (laboratory) and in vivo (animal) experiments. In the animal study, the xanthohumol-loaded scaffolds, along with bone marrow stem cells, were implanted into goats to observe cartilage regeneration and anti-inflammatory effects.
The use of xanthohumol-loaded scaffolds can potentially improve the success rate of cartilage repair procedures by reducing inflammation and promoting better cartilage regeneration.
The study provides a foundation for the clinical translation of tissue-engineered cartilage constructs, particularly in addressing the challenge of inflammation-induced failure of cartilage regeneration.
The findings support the development of new scaffold designs that incorporate anti-inflammatory agents to enhance tissue regeneration in various applications.